Abstract
Purpose of Review
Discogenic low back pain (DLBP) stems from pathology in one or more intervertebral discs identified as the root cause of the pain. It is the most common type of chronic low back pain (LBP), representing 26–42% of attributable cases.
Recent Findings
The clinical presentation of DLBP includes increased pain when sitting, coughing, or sneezing, and experiencing relief when standing or ambulating. Dermatomal radiation of pain to the lower extremity and neurological symptoms including numbness, motor weakness, and urinary or fecal incontinence are signs of advanced disease with disc prolapse, nerve root compression, or spinal stenosis. Degenerative disc disease is caused by both a decrease in disc nutrient supply causing decreased oxygen, lowered pH, and lessened ability of the intervertebral disc (IVD) to respond to increased load or injury; moreover, changes in the extracellular matrix composition cause weakening of the tissue and skewing the extracellular matrix’s (ECM) harmonious balance between catabolic and anabolic factors for cell turnover in favor of catabolism. Thus, the degeneration of the disc causes a shift from type II to type I collagen expression by NP cells and a decrease in aggrecan synthesis leads to dehydrated matrix cells ultimately with loss of swelling pressure needed for mechanical support. Cell-based therapies such as autologous nucleus pulposus cell re-implantation have in animal models and human trials shown improvements in LBP score, retention of hydration in IVD, and increased disc height. Percutaneously delivered multipotent mesenchymal stem cell (MSC) therapy has been proposed as a potential means to uniquely ameliorate discogenic LBP holistically through three mechanisms: mitigation of primary nociceptive disc pain, slow or reversal of the catabolic metabolism, and restoration of disc tissue. Embryonic stem cells (ESCs) can differentiate into cells of all three germ layers in vitro, but their use is hindered related to ethical concerns, potential for immune rejection after transplantation, disease, and teratoma formation. Another similar approach to treating back pain is transplantation of the nucleus pulposus, which, like stem cell therapy, seeks to address the underlying cause of intervertebral disc degeneration by aiming to reverse the destructive inflammatory process and regenerate the proteoglycans and collagen found in healthy disc tissue.
Summary
Preliminary animal models and clinical studies have shown mesenchymal stem cell implantation as a potential therapy for IVD regeneration and ECM restoration via a shift towards favorable anabolic balance and reduction of pain.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Bernstein IA, Malik Q, Carville S, Ward S. Low back pain and sciatica: summary of NICE guidance. BMJ 2017;356:i6748.
Cassidy JD, Carroll LJ, Côté P. The Saskatchewan health and back pain survey. The prevalence of low back pain and related disability in Saskatchewan adults. Spine (Phila Pa 1976). 1998;23:1860–6; discussion 1867.
Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine (Phila Pa 1976). 1987;12:264–8.
Longo UG, Loppini M, Denaro L, Maffulli N, Denaro V. Rating scales for low back pain. Br Med Bull Oxford University Press; 2010;94:81–144.
Atlas SJ, Deyo RA. Evaluating and managing acute low back pain in the primary care setting. J Gen Intern Med Springer; 2001;16:120–31.
Petering RC, Webb C. Treatment options for low back pain in athletes. Sports Health. SAGE Publications; 2011;3:550–5.
Deyo RA, Mirza SK, Martin BI. Back pain prevalence and visit rates. Spine (Phila Pa 1976). 2006;31:2724–7.
Deyo RA, Weinstein JN. Low back pain. N Engl J Med. 2001;344:363–70.
Skovron ML, Szpalski M, Nordin M, Melot C, Cukier D. Sociocultural factors and back pain. A population-based study in Belgian adults. Spine (Phila Pa 1976). 1994;19:129–37.
Katz JN. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. J Bone Joint Surg Am. 2006;88(Suppl 2):21–4.
Deyo RA, Loeser JD, Bigos SJ. Herniated lumbar intervertebral disk. Ann Intern Med. 1990;112:598–603.
Croft PR, Papageorgiou AC, Ferry S, Thomas E, Jayson MI, Silman AJ. Psychologic distress and low back pain. Evidence from a prospective study in the general population. Spine (Phila Pa 1976). 1995;20:2731–7.
Croft PR, Papageorgiou AC, Thomas E, Macfarlane GJ, Silman AJ. Short-term physical risk factors for new episodes of low back pain. Prospective evidence from the South Manchester Back Pain Study. Spine (Phila Pa 1976). 1999;24:1556–61.
Macfarlane GJ, Thomas E, Papageorgiou AC, Croft PR, Jayson MI, Silman AJ. Employment and physical work activities as predictors of future low back pain. Spine (Phila Pa 1976). 1997;22:1143–9.
Steffens D, Ferreira ML, Latimer J, Ferreira PH, Koes BW, Blyth F, et al. What triggers an episode of acute low back pain? A case-crossover study. Arthritis Care Res. 2015;67:403–10.
• Chou R, Qaseem A, Snow V, Casey D, Cross JT, Shekelle P, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med American College of Physicians; 2007;147:478. Clinical recommendations by the American Pain Society and American College of Physicians for the diagnosis and treatment of low back pain
Chou R, Qaseem A, Owens DK, Shekelle P. Clinical Guidelines Committee of the American College of Physicians. Diagnostic imaging for low back pain: advice for high-value health care from the American College of Physicians. Ann Intern Med. 2011;154:181–9. Clinical recommendations by the American College of Physicians for the diagnosis of low back pain.
Heuch I, Foss IS. Acute low back usually resolves quickly but persistent low back pain often persists. J Physiother. 2013;59:127.
Parthan A, Evans CJ, Le K. Chronic low back pain: epidemiology, economic burden and patient-reported outcomes in the USA. Expert Rev Pharmacoecon Outcomes Res. 2006;6:359–69.
Dowdell J, Erwin M, Choma T, Vaccaro A, Iatridis J, Cho SK. Intervertebral disk degeneration and repair. Neurosurgery. 2017;80:S46–54.
Zhang Y, Guo T, Guo X, Wu S. Clinical diagnosis for discogenic low back pain. Int J Biol Sci 2009;5:647–58.
Peng B-G. Pathophysiology, diagnosis, and treatment of discogenic low back pain. World J Orthop. 2013;4:42. Available from: http://www.wjgnet.com/2218-5836/full/v4/i2/42.htm-52. Accessed 1 Mar 2019.
Kim KD. Stem cells and discogenic low back pain. Spine (Phila Pa 1976). 2016;41:S11–2.
Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, et al. Lumbar intradiskal platelet-rich plasma (PRP) injections: a prospective, double-blind, randomized controlled study. PM&R. 2016;8:1–10.
Laslett M, Oberg B, Aprill CN, McDonald B. Centralization as a predictor of provocation discography results in chronic low back pain, and the influence of disability and distress on diagnostic power. Spine J 2005;5(4):370–80.
Yrjämä M, Vanharanta H. Bony vibration stimulation: a new, non-invasive method for examining intradiscal pain. Eur Spine J. 1994;3:233–5.
Choi Y-S. Pathophysiology of degenerative disc disease. Asian Spine J. 2009;3:39–44.
Richardson SM, Kalamegam G, Pushparaj PN, Matta C, Memic A, Khademhosseini A, et al. Mesenchymal stem cells in regenerative medicine: focus on articular cartilage and intervertebral disc regeneration. Methods. 2016;99:69–80.
Zeckser J, Wolff M, Tucker J, Goodwin J. Multipotent mesenchymal stem cell treatment for discogenic low back pain and disc degeneration. Stem Cells Int Hindawi Publishing Corporation; 2016;2016:4–6.
Carragee EJ, Lincoln T, Parmar VS, Alamin T. A gold standard evaluation of the “discogenic pain” diagnosis as determined by provocative discography. Spine (Phila Pa 1976). 2006;31:2115–23.
Kluner C, Kivelitz D, Rogalla P, Putzier M, Hamm B, Enzweiler C. Percutaneous discography: comparison of low-dose CT, fluoroscopy and MRI in the diagnosis of lumbar disc disruption. Eur Spine J. 2006;15:620–6.
Yrjama M, Tervonen O, Vanharanta H. Ultrasonic imaging of lumbar discs combined with vibration pain provocation compared with discography in the diagnosis of internal anular fissures of the lumbar spine. Spine (Phila Pa 1976). 1996.
Rannou F, Ouanes W, Boutron I, Lovisi B, Fayad F, Macé Y, et al. High-sensitivity C-reactive protein in chronic low back pain with vertebral end-plate Modic signal changes. Arthritis Rheum. 2007;57:1311–5.
Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics. 2005;5:3226–45.
Hadjipavlou AG, Tzermiadianos MN, Bogduk N, Zindrick MR. The pathophysiology of disc degeneration: a critical review. J Bone Joint Surg (Br). 2008;90:1261–70.
Peng B, Hao J, Hou S, Wu W, Jiang D, Fu X, et al. Possible pathogenesis of painful intervertebral disc degeneration. Spine (Phila Pa 1976). 2006;31:560–6.
Nagano T, Yonenobu K, Miyamoto S, Tohyama M, Ono K. Distribution of the basic fibroblast growth factor and its receptor gene expression in normal and degenerated rat intervertebral discs. Spine (Phila Pa 1976). 1995;20:1972–8.
• Liu X, Krishnamoorthy D, Lin L, Xue P, Zhang F, Chi L, et al. A method for characterising human intervertebral disc glycosaminoglycan disaccharides using liquid chromatography-mass spectrometry with multiple reaction monitoring. Eur Cell Mater. 2018;35:117–31.
Peng B, Chen J, Kuang Z, Li D, Pang X, Zhang X. Expression and role of connective tissue growth factor in painful disc fibrosis and degeneration. Spine (Phila Pa 1976). 2009;34:E178–82.
Edgar MA. The nerve supply of the lumbar intervertebral disc. J Bone Jt Surg - Br Vol. 2007;89-B:1135–9.
He L, Hu X, Tang Y, Li X, Zheng S, Ni J. Efficacy of coblation annuloplasty in discogenic low back pain: a prospective observational study. Medicine. 2015;94:e846.
Suseki K, Takahashi Y, Takahashi K, Chiba T, Yamagata M, Moriya H. Sensory nerve fibres from lumbar intervertebral discs pass through rami communicantes. a possible pathway for discogenic low back pain. J Bone Joint Surg (Br). 1998;80:737–42.
Allegri M, Montella S, Salici F, Valente A, Marchesini M, Compagnone C, et al. Mechanisms of low back pain: a guide for diagnosis and therapy. F1000Research. 2016;5:1530 Available from: https://f1000research.com/articles/5-1530/v2. Accessed 1 Mar 2019.
Manchikanti L, Singh V. Evaluation of the relative contributions of various structures in chronic low back pain. Pain Physician. 2001;
•• Kumar H, Ha D-H, Lee E-J, Park JH, Shim JH, Ahn T-K, et al. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study. Stem Cell Res Ther. 2017;8:262 Long-term follow-up of intradiscal implantation of mesenchymal stem cells for chronic low back pain.
Mohammed S, Yu J. Platelet-rich plasma injections: an emerging therapy for chronic discogenic low back pain. J Spine Surg. 2018;4:115–22.
Cornejo MC, Cho SK, Giannarelli C, Iatridis JC, Purmessur D. Soluble factors from the notochordal-rich intervertebral disc inhibit endothelial cell invasion and vessel formation in the presence and absence of pro-inflammatory cytokines. Osteoarthr Cartil. 2015;23:487–96.
Carragee EJ, Don AS, Hurwitz EL, Cuellar JM, Carrino J, Herzog R, et al. ISSLS prize winner: does discography cause accelerated progression of degeneration changes in the lumbar disc. Spine (Phila Pa 1976). 2009;34:2338–45.
Nassr A, Lee JY, Bashir RS, Rihn JA, Eck JC, Kang JD, et al. Does incorrect level needle localization during anterior cervical discectomy and fusion lead to accelerated disc degeneration? Spine (Phila Pa 1976). 2009;34:189–92.
Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol. 2004;204:47–54.
Hohaus C, Ganey TM, Minkus Y, Meisel HJ. Cell transplantation in lumbar spine disc degeneration disease. Eur Spine J Springer-Verlag; 2008;17:492–503.
Meisel HJ, Siodla V, Ganey T, Minkus Y, Hutton WC, Alasevic OJ. Clinical experience in cell-based therapeutics: disc chondrocyte transplantation: a treatment for degenerated or damaged intervertebral disc Biomol Eng Elsevier; 2007;24:5–21.
Sakai D, Andersson GBJ. Stem cell therapy for intervertebral disc regeneration: obstacles and solutions. Nat Rev Rheumatol Nature Publishing Group; 2015;11:243–56.
Sivakamasundari V, Lufkin T. Stemming the degeneration: IVD stem cells and stem cell regenerative therapy for degenerative disc disease. Adv stem cells. 2013;2013.
Caplan AI. All MSCs are pericytes? Cell Stem Cell. Elsevier; 2008;3:229–30.
Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell Cell Press; 2011;9:11–5.
Wakao S, Kuroda Y, Ogura F, Shigemoto T, Dezawa M, Wakao S, et al. Regenerative effects of mesenchymal stem cells: contribution of muse cells, a novel pluripotent stem cell type that resides in mesenchymal cells. Cells Multidisciplinary Digital Publishing Institute; 2012;1:1045–60.
Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res NIH Public Access; 2007;100:1249–60.
Karin Wuertz KGCNJUJCI. Behavior of mesenchymal stem cells in the chemical microenvironment of the intervertebral disc. Spine (Phila Pa 1976). 2008;33:1843–9.
Stoyanov JV, Gantenbein-Ritter B, Bertolo A, Aebli N, Baur M, Alini M, et al. Role of hypoxia and growth and differentiation factor-5 on differentiation of human mesenchymal stem cells towards intervertebral nucleus pulposus-like cells. Eur Cells Mater. 2011;21:533–47.
Liang C, Li H, Tao Y, Zhou X, Li F, Chen G, et al. Responses of human adipose-derived mesenchymal stem cells to chemical microenvironment of the intervertebral disc. J Transl Med. BioMed Central; 2012;10:49.
Feng G, Zhao X, Liu H, Zhang H, Chen X, Shi R, et al. Transplantation of mesenchymal stem cells and nucleus pulposus cells in a degenerative disc model in rabbits: a comparison of 2 cell types as potential candidates for disc regeneration. J Neurosurg Spine. 2011;14:322–9.
Acosta FL, Metz L, Adkisson HD, Liu J, Carruthers-Liebenberg E, Milliman C, et al. Porcine intervertebral disc repair using allogeneic juvenile articular chondrocytes or mesenchymal stem cells. Tissue Eng Part A. 2011;17:3045–55.
Wu T, Song H, Dong Y, Li J. Cell-based therapies for lumbar discogenic low back pain. Spine (Phila Pa 1976). 2018;43:49–57.
Henriksson HB, Hagman M, Horn M, Lindahl A, Brisby H. Investigation of different cell types and gel carriers for cell-based intervertebral disc therapy, in vitro and in vivo studies. J Tissue Eng Regen Med Wiley-Blackwell; 2012;6:738–47.
Wang Z, Perez-Terzic CM, Smith J, Mauck WD, Shelerud RA, Maus TP, et al. Efficacy of intervertebral disc regeneration with stem cells — a systematic review and meta-analysis of animal controlled trials. Gene. 2015;564:1–8.
Gantenbein B, Illien-Jünger S, Chan S, Walser J, Haglund L, Ferguson S, et al. Organ culture bioreactors – platforms to study human intervertebral disc degeneration and regenerative therapy. Curr Stem Cell Res Ther. 2015;10:339–52.
Korecki CL, MacLean JJ, Iatridis JC. Characterization of an in vitro intervertebral disc organ culture system. Eur Spine J Springer-Verlag; 2007;16:1029–37.
Gawri R, Mwale F, Ouellet J, Roughley PJ, Steffen T, Antoniou J, et al. Development of an organ culture system for long-term survival of the intact human intervertebral disc. Spine (Phila Pa 1976). 2011;36:1835–42.
•• Teixeira GQ, Pereira CL, Ferreira JR, Maia AF, Gomez-Lazaro M, Barbosa MA, et al. Immunomodulation of human mesenchymal stem/stromal cells in intervertebral disc degeneration. Spine (Phila Pa 1976). 2018;43:E673–82 An investigation of immunomodulation to improve the efficacy of stem cell implantation.
Miguélez-Rivera L, Pérez-Castrillo S, González-Fernández ML, Prieto-Fernández JG, López-González ME, García-Cosamalón J, et al. Immunomodulation of mesenchymal stem cells in discogenic pain. Spine J. 2018;18:330–42.
Wang W, Wang Y, Deng G, Ma J, Huang X, Yu J, et al. Transplantation of hypoxic-preconditioned bone mesenchymal stem cells retards intervertebral disc degeneration via enhancing implanted cell survival and migration in rats. Stem Cells Int Hindawi; 2018;2018:1–13.
Lehmann TP, Jakub G, Harasymczuk J, Jagodziński PP. Transforming growth factor β mediates communication of co-cultured human nucleus pulposus cells and mesenchymal stem cells. J Orthop Res. 2018;36:3023–32.
Maidhof R, Rafiuddin A, Chowdhury F, Jacobsen T, Chahine NO. Timing of mesenchymal stem cell delivery impacts the fate and therapeutic potential in intervertebral disc repair. J Orthop Res. 2017;35:32–40.
Hang D, Li F, Che W, Wu X, Wan Y, Wang J, et al. One-stage positron emission tomography and magnetic resonance imaging to assess mesenchymal stem cell survival in a canine model of intervertebral disc degeneration. Stem Cells Dev. 2017;26:1334–43.
Steffen F, Smolders LA, Roentgen AM, Bertolo A, Stoyanov J. Bone marrow-derived mesenchymal stem cells as autologous therapy in dogs with naturally occurring intervertebral disc disease: feasibility, safety, and preliminary results. Tissue Eng Part C Methods. 2017;23:643–51.
Yoshikawa T, Ueda Y, Miyazaki K, Koizumi M, Takafumi Yoshikawa MD, Yurito Ueda MD, et al. Disc regeneration therapy using marrow mesenchymal cell transplantation: a report of two case studies. Spine (Phila Pa 1976). 2010;35:E475–80.
Orozco L, Soler R, Morera C, Alberca M, Sánchez A, García-Sancho J. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 2011;92:822–8.
Pettine KA, Murphy MB, Suzuki RK, Sand TT. Percutaneous injection of autologous bone marrow concentrate cells significantly reduces lumbar discogenic pain through 12 months. Stem Cells. 2015;33:146–56.
Pettine K, Suzuki R, Sand T, Murphy M. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up. Int Orthop. 2016;40:135–40.
Pettine KA, Suzuki RK, Sand TT, Murphy MB. Autologous bone marrow concentrate intradiscal injection for the treatment of degenerative disc disease with three-year follow-up. Int Orthop. 2017;41:2097–103.
Elabd C, Centeno CJ, Schultz JR, Lutz G, Ichim T, Silva FJ. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study. J Transl Med BioMed Central; 2016;14:1–9.
Centeno C, Markle J, Dodson E, Stemper I, Williams CJ, Hyzy M, et al. Treatment of lumbar degenerative disc disease-associated radicular pain with culture-expanded autologous mesenchymal stem cells: a pilot study on safety and efficacy. J Transl Med BioMed Central; 2017;15:1–12.
Noriega DC, Ardura F, Hernández-Ramajo R, Martín-Ferrero MÁ, Sánchez-Lite I, Toribio B, et al. Intervertebral disc repair by allogeneic mesenchymal bone marrow cells: a randomized controlled trial. Transplantation. 2017;101:1945–51.
•• Perez-Cruet M, Beeravolu N, McKee C, Brougham J, Khan I, Bakshi S, et al. Potential of human nucleus pulposus-like cells derived from umbilical cord to treat degenerative disc disease. Neurosurgery. 2018;0:1–12 An investigation of umbilical cord derived nucleus pulposus like cells for the treatmentof degenerative disc disease.
Nukaga T, Sakai D, Tanaka M, Hiyama A, Nakai T, Mochida J. Transplantation of activated nucleus pulposus cells after cryopreservation: efficacy study in a canine disc degeneration model. Eur Cells Mater. 2016;31:95–106.
Mochida J, Sakai D, Nakamura Y, Watanabe T, Yamamoto Y, Kato S. Intervertebral disc repair with activated nucleus pulposus cell transplantation: a three-year, prospective clinical study of its safety. Eur Cells Mater. 2015;29:202–12.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Ivan Urits, Alexander Capuco, Medha Sharma, Omar Viswanath, Elyse M. Cornett, and Vwaire Orhurhu declare no conflict of interest. Alan D. Kaye discloses that he is on the Speakers Bureau for Depomed, Inc. and Merck.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Hot Topics in Pain and Headache
Rights and permissions
About this article
Cite this article
Urits, I., Capuco, A., Sharma, M. et al. Stem Cell Therapies for Treatment of Discogenic Low Back Pain: a Comprehensive Review. Curr Pain Headache Rep 23, 65 (2019). https://doi.org/10.1007/s11916-019-0804-y
Published:
DOI: https://doi.org/10.1007/s11916-019-0804-y